Galera Therapeutics Explores Strategic Options Amid Financial Results Announcement
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company, has released its financial outcomes for the first quarter ending March 31, 2024, and concurrently provided insights into …
Galera Therapeutics Explores Strategic Options Amid Financial Results Announcement Read More